Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 745,629
  • Shares Outstanding, K 60,326
  • Annual Sales, $ 1,580 K
  • Annual Income, $ -161,340 K
  • 60-Month Beta 1.16
  • Price/Sales 475.35
  • Price/Cash Flow N/A
  • Price/Book 1.72
Trade PLRX with:

Options Overview Details

View History
  • Implied Volatility 95.50% ( -10.56%)
  • Historical Volatility 56.35%
  • IV Percentile 89%
  • IV Rank 47.34%
  • IV High 143.78% on 07/05/24
  • IV Low 52.08% on 12/19/23
  • Put/Call Vol Ratio 0.54
  • Today's Volume 63
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 7,766
  • Open Int (30-Day) 7,715

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.85
  • Number of Estimates 7
  • High Estimate -0.80
  • Low Estimate -0.93
  • Prior Year -0.70
  • Growth Rate Est. (year over year) -21.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.29 +20.12%
on 07/05/24
13.83 -10.63%
on 07/16/24
+1.65 (+15.41%)
since 06/18/24
3-Month
10.29 +20.12%
on 07/05/24
16.52 -25.18%
on 05/15/24
-0.16 (-1.28%)
since 04/19/24
52-Week
10.29 +20.12%
on 07/05/24
20.23 -38.90%
on 08/04/23
-5.46 (-30.64%)
since 07/19/23

Most Recent Stories

More News
Why Shares of Pliant Therapeutics Are Rising Tuesday

The company's lead therapy fared well in a phase 2a trial to treat two separate conditions.

PLRX : 12.36 (-0.72%)
Why Pliant Therapeutics Stock Is Skyrocketing This Week

The company's experimental idiopathic pulmonary fibrosis drug is showing a lot of promise.

PLRX : 12.36 (-0.72%)
Pliant Therapeutics Gaps 34% Higher: More Upside To Come?

Pliant Therapeutics zoomed 34% higher and added to that gain in the next session.This followed good news about clinical trials for a lung-condition treatment.

PLRX : 12.36 (-0.72%)
NVS : 106.13 (-1.02%)
CPRX : 16.94 (+1.32%)
NBIX : 145.69 (+1.08%)
Pliant Therapeutics (NASDAQ: PLRX) Reports Positive Phase 2 Clinical Trial Data of Bexotegrast in Treatment of Idiopathic Pulmonary Fibrosis

Pliant Therapeutics, Inc. (NASDAQ: PLRX) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

PLRX : 12.36 (-0.72%)
Pre-Market Brief: Stocks Mixed As Investors Brace For Tech Earnings

March S&P 500 futures (ESH23) are trending down -0.19% this morning after three major U.S. benchmark indices rallied on Friday, with the S&P 500 and Dow snapping a three-session losing streak and the Nasdaq...

ESH23 : 3,957.05s (-0.09%)
NFLX : 633.34 (-1.51%)
GOOGL : 177.66 (-0.02%)
ALLY : 41.86 (-1.37%)
MSFT : 437.11 (-0.74%)
IBM : 183.25 (-1.06%)
TSLA : 239.20 (-4.02%)
INTC : 32.98 (-5.42%)
RCO.FP : 73.000 (+2.46%)
PLRX : 12.36 (-0.72%)
LCID : 3.50 (-1.96%)
BBBY : 0.0751 (-27.09%)
3 Soaring Biotech Stocks That Could Climb Much Higher

These drugmakers have bucked the overall market's downward trend this year and expectations are still high.

BLTE : 50.33 (+3.45%)
CINC : 29.06 (-0.48%)
PLRX : 12.36 (-0.72%)
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused...

PLRX : 12.36 (-0.72%)
2022 Roundtable: Our Favorite Picks Right Now

Here's why we like Novavax, Orthopediatrics, and Pliant Therapeutics.

NVAX : 13.85 (-7.42%)
KIDS : 32.57 (-3.38%)
PLRX : 12.36 (-0.72%)
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Primary Sclerosing Cholangitis

SOUTH SAN FRANCISCO, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics (NASDAQ: PLRX) announced today that PLN-74809, its oral,...

PLRX : 12.36 (-0.72%)
Could Pliant Therapeutics Stock Double Your Money?

Wall Street thinks this red-hot biotech stock has a lot more room to run.

NVS : 106.13 (-1.02%)
PLRX : 12.36 (-0.72%)

Business Summary

Pliant Therapeutics Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing novel therapies for the treatment of fibrosis. The company's lead product consist PLN-74809 and PLN-1474 which are in clinical stage. Pliant Therapeutics Inc. is based in SAN FRANCISCO,...

See More

Key Turning Points

3rd Resistance Point 13.22
2nd Resistance Point 12.97
1st Resistance Point 12.66
Last Price 12.36
1st Support Level 12.10
2nd Support Level 11.85
3rd Support Level 11.54

See More

52-Week High 20.23
Fibonacci 61.8% 16.43
Fibonacci 50% 15.26
Fibonacci 38.2% 14.09
Last Price 12.36
52-Week Low 10.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar